-
Weather to Play Major Role in Coronavirus Spread
contractpharma
March 17, 2020
Researchers predict potential spread and seasonality for COVID-19 based on climate where virus appears to thrive.
-
University of California Develops Coronavirus Test
contractpharma
March 16, 2020
Labs at UC San Francisco, UCLA and UC San Diego are now offering the in-house COVID-19 tests.
-
PharmaMar Reports Positive Results for Aplidin Against Coronavirus
contractpharma
March 16, 2020
Therapeutic target of Aplidin (plitidepsin), which is EF1A, is key to the multiplication and spread of the virus.
-
Roche’s SARS-CoV-2 Test Receives EUA
contractpharma
March 16, 2020
First commercial test for SARS-CoV-2 will enable expedited coronavirus testing with results in three and half hours.
-
Elsevier Gives Full Access to its Content on its COVID-19 Information Center for PubMed Central and Other Public Health Databases to Accelerate Fight Against Coronavirus
PRNewswire
March 16, 2020
Elsevier is making all its research and data content on its COVID-19 Information Center available to PubMed Central, the archive of biomedical and lifescience at the US National Institutes of Health's National Library of Medicine, and the other publicly f
-
International Psoriasis Council Statement On The Coronavirus (COVID-19) Outbreak
prnasia
March 14, 2020
The rapid spread of the coronavirus (COVID-19) is a serious public health concern. It remains unknown to what extent the coronavirus impacts psoriasis and the treatment of psoriasis.
-
Doo Holding Group Donates 30,000 Masks to Hubei Hospitals
prnasia
March 14, 2020
Financial technology and services conglomerate Doo Holding Group Limited has donated medical-grade PPE to hospitals in the Province of Hubei to help in the fight against the coronavirus.
-
Bayer Shuts Down Locations amid COVID-19 Concerns
americanpharmaceuticalreview
March 13, 2020
Bayer will temporarily closing locations inNew Jersey locations and Missouri over concerns that an employee may have contracted COVID-19.
-
Tiziana Developing TZLS-501 as Potential Coronavirus Treatment
americanpharmaceuticalreview
March 13, 2020
Tiziana Life Sciences has announced that its TZLS-501 treatment could be a potential treatment for patients infected with coronavirus (COVID-19) who are at risk of respiratory failure.
-
Landmark investment for life sciences in UK government Budget
europeanpharmaceuticalreview
March 13, 2020
The UK government has pledged funding of £22 billion per year into R&D by 2025 in its Budget, just days after a further £46 million was invested into coronavirus research.